|
Re: Their finest hour
|
9
|
Resverlogix Corp.
|
Sep 24, 2019 04:02PM
|
|
Re: The thread has been killed
|
4
|
Resverlogix Corp.
|
Jun 12, 2019 04:18PM
|
|
Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
9
|
Resverlogix Corp.
|
Dec 16, 2021 02:26PM
|
|
Re: Technicals have looked good before....
|
5
|
Resverlogix Corp.
|
Sep 01, 2016 03:41PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
3
|
Resverlogix Corp.
|
Jun 13, 2020 04:43PM
|
|
Re: Short interest
|
2
|
Resverlogix Corp.
|
Apr 02, 2021 05:36PM
|
|
Re: RVX rises above 200-day moving average
|
6
|
Resverlogix Corp.
|
Sep 21, 2020 03:26PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
10
|
Resverlogix Corp.
|
Jan 18, 2021 01:26PM
|
|
Re: RVX announces first right of refusal for license deal in the US
|
10
|
Resverlogix Corp.
|
Oct 24, 2017 05:05PM
|
|
Re: RVX AGM and Zenith AGM, my thoughts
|
4
|
Resverlogix Corp.
|
Sep 13, 2016 01:45AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
10
|
Resverlogix Corp.
|
Oct 14, 2020 03:00PM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Oct 07, 2016 11:05AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 05:38PM
|
|
Re: Quote from a January 19, 2021 review
|
12
|
Resverlogix Corp.
|
Jan 21, 2021 08:31AM
|
|
Re: Quote from a January 19, 2021 review
|
6
|
Resverlogix Corp.
|
Jan 21, 2021 03:46PM
|
|
Re: Questions for Q1 webcast
|
8
|
Resverlogix Corp.
|
Mar 18, 2016 06:13PM
|
|
Re: Peer Reviewed.....A question for the board
|
7
|
Resverlogix Corp.
|
Jan 24, 2016 05:26AM
|
|
Re: p-values : are correct
|
10
|
Resverlogix Corp.
|
Feb 24, 2017 09:27AM
|
|
Re: Our own BKC on the webcast
|
8
|
Resverlogix Corp.
|
Feb 04, 2021 12:49PM
|
|
Re: Odd
|
13
|
Resverlogix Corp.
|
Dec 08, 2020 04:31AM
|
